Status:
COMPLETED
Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer
Lead Sponsor:
Indiana University School of Medicine
Collaborating Sponsors:
Breast Cancer Research Foundation
Conditions:
Breast Cancer Stage IV
Breast Cancer Stage I
Eligibility:
FEMALE
18+ years
Brief Summary
We propose to quantitate endothelial progenitor cells (EPCs) in early and advanced breast cancer patients. Peripheral blood will be drawn from the eligible patients. Different type of EPCs will be iso...
Detailed Description
Accumulating evidence emphasizes the emerging role of circulating endothelial cells (CECs) and endothelial progenitor cells (EPCs) in tumor angiogenesis as surrogate markers and in the efficacy of ant...
Eligibility Criteria
Inclusion
- Diagnosis of metastatic breast cancer(stage IV), or women with a history of Stage I or II breast cancer disease who are currently disease free Women greater than or equal to 18 years of age Ability to understand and the willingness to sign an informed consent
Exclusion
- Chemotherapy, radiation, or surgery within the past 4 weeks.
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT00393341
Start Date
October 1 2006
End Date
August 1 2009
Last Update
August 31 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University
Indianapolis, Indiana, United States, 46202